Literature DB >> 25196529

PTH receptor signaling in osteoblasts regulates endochondral vascularization in maintenance of postnatal growth plate.

Tao Qiu1, Lingling Xian, Janet Crane, Chunyi Wen, Matthew Hilton, William Lu, Peter Newman, Xu Cao.   

Abstract

Longitudinal growth of postnatal bone requires precise control of growth plate cartilage chondrocytes and subsequent osteogenesis and bone formation. Little is known about the role of angiogenesis and bone remodeling in maintenance of cartilaginous growth plate. Parathyroid hormone (PTH) stimulates bone remodeling by activating PTH receptor (PTH1R). Mice with conditional deletion of PTH1R in osteoblasts showed disrupted trabecular bone formation. The mice also exhibited postnatal growth retardation with profound defects in growth plate cartilage, ascribable predominantly to a decrease in number of hypertrophic chondrocytes, resulting in premature fusion of the growth plate and shortened long bones. Further characterization of hypertrophic zone and primary spongiosa revealed that endochondral angiogenesis and vascular invasion of the cartilage were impaired, which was associated with aberrant chondrocyte maturation and cartilage development. These studies reveal that PTH1R signaling in osteoblasts regulates cartilaginous growth plate for postnatal growth of bone.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  GROWTH PLATE; PARATHYROID HORMONE; POSTNATAL BONE GROWTH; VASCULARIZATION

Mesh:

Substances:

Year:  2015        PMID: 25196529      PMCID: PMC4730385          DOI: 10.1002/jbmr.2327

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  37 in total

1.  Fetal parathyroids are not required to maintain placental calcium transport.

Authors:  C S Kovacs; N R Manley; J M Moseley; T J Martin; H M Kronenberg
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Osteoblast-derived PTHrP is a physiological regulator of bone formation.

Authors:  T John Martin
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

3.  Parathyroid hormone is essential for normal fetal bone formation.

Authors:  Dengshun Miao; Bin He; Andrew C Karaplis; David Goltzman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions.

Authors:  G S Duncan; D P Andrew; H Takimoto; S A Kaufman; H Yoshida; J Spellberg; J L de la Pompa; A Elia; A Wakeham; B Karan-Tamir; W A Muller; G Senaldi; M M Zukowski; T W Mak
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

5.  Antiangiogenic treatment delays chondrocyte maturation and bone formation during limb skeletogenesis.

Authors:  Melinda Yin; Chiara Gentili; Eiki Koyama; Michael Zasloff; Maurizio Pacifici
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

6.  Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.

Authors:  Daniel D Bikle; Takeshi Sakata; Colin Leary; Hashem Elalieh; David Ginzinger; Clifford J Rosen; Wesley Beamer; Sharmila Majumdar; Bernard P Halloran
Journal:  J Bone Miner Res       Date:  2002-09       Impact factor: 6.741

7.  Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.

Authors:  Mei Zhang; Shouhong Xuan; Mary L Bouxsein; Dietrich von Stechow; Nagako Akeno; Marie Claude Faugere; Hartmut Malluche; Guisheng Zhao; Clifford J Rosen; Argiris Efstratiadis; Thomas L Clemens
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

8.  The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C.

Authors:  Jun Guo; Ung-Il Chung; Hisatomo Kondo; F Richard Bringhurst; Henry M Kronenberg
Journal:  Dev Cell       Date:  2002-08       Impact factor: 12.270

9.  PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps.

Authors:  Tatsuya Kobayashi; Ung-Il Chung; Ernestina Schipani; Michael Starbuck; Gerard Karsenty; Takenobu Katagiri; Dale L Goad; Beate Lanske; Henry M Kronenberg
Journal:  Development       Date:  2002-06       Impact factor: 6.868

10.  Endothelial Notch activity promotes angiogenesis and osteogenesis in bone.

Authors:  Saravana K Ramasamy; Anjali P Kusumbe; Lin Wang; Ralf H Adams
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

View more
  19 in total

Review 1.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

2.  PTH Signaling in Osteoprogenitors Is Essential for B-Lymphocyte Differentiation and Mobilization.

Authors:  Cristina Panaroni; Keertik Fulzele; Vaibhav Saini; Rhiannon Chubb; Paola Divieti Pajevic; Joy Y Wu
Journal:  J Bone Miner Res       Date:  2015-07-20       Impact factor: 6.741

3.  The Notch pathway regulates the bone gain induced by PTH anabolic signaling.

Authors:  Jesus Delgado-Calle; Kevin McAndrews; Gerald Wu; Ashley L Orr; Adam Ferrari; Xiaolin Tu; Venkatesan Srinivasan; G David Roodman; Frank H Ebetino; Robert K Boeckman; Teresita Bellido
Journal:  FASEB J       Date:  2022-03       Impact factor: 5.834

4.  Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.

Authors:  Samantha R Weaver; Earnest L Taylor; Elizabeth L Zars; Katherine M Arnold; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2021-02-08       Impact factor: 6.741

5.  CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.

Authors:  Gexin Zhao; Elliot W Kim; Jie Jiang; Chimay Bhoot; Kemberly R Charles; Jongseung Baek; Subburaman Mohan; John S Adams; Sotirios Tetradis; Karen M Lyons
Journal:  J Bone Miner Res       Date:  2020-08-17       Impact factor: 6.390

6.  Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.

Authors:  Wengui Xie; Lixin Ji; Teng Zhao; Pengfei Gao
Journal:  Med Sci Monit       Date:  2015-05-09

7.  IGF-I induced phosphorylation of PTH receptor enhances osteoblast to osteocyte transition.

Authors:  Tao Qiu; Janet L Crane; Liang Xie; Lingling Xian; Hui Xie; Xu Cao
Journal:  Bone Res       Date:  2018-02-26       Impact factor: 13.567

8.  Intermittent parathyroid hormone (1-34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis.

Authors:  Ena Music; Kathryn Futrega; James S Palmer; Mackenzie Kinney; Bill Lott; Travis J Klein; Michael R Doran
Journal:  Stem Cell Res Ther       Date:  2020-07-29       Impact factor: 6.832

9.  Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.

Authors:  David E Maridas; Elizabeth Rendina-Ruedy; Ron C Helderman; Victoria E DeMambro; Daniel Brooks; Anyonya R Guntur; Beate Lanske; Mary L Bouxsein; Clifford J Rosen
Journal:  FASEB J       Date:  2018-10-24       Impact factor: 5.834

10.  Ciliary parathyroid hormone signaling activates transforming growth factor-β to maintain intervertebral disc homeostasis during aging.

Authors:  Liwei Zheng; Yong Cao; Shuangfei Ni; Huabin Qi; Zemin Ling; Xin Xu; Xuenong Zou; Tianding Wu; Ruoxian Deng; Bo Hu; Bo Gao; Hao Chen; Yusheng Li; Jianxi Zhu; Francis Tintani; Shadpour Demehri; Amit Jain; Khaled M Kebaish; Shenghui Liao; Cheryle A Séguin; Janet L Crane; Mei Wan; Hongbin Lu; Paul D Sponseller; Lee H Riley; Xuedong Zhou; Jianzhong Hu; Xu Cao
Journal:  Bone Res       Date:  2018-07-18       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.